参考文献/References:
[1] Rienks M,Papageorgiou AP,Frangogiannis NG,et al. Myocardial extracellular matrixan ever-changing and diverse entity[J]. Circ Res,2014,114(5):872-888.
[2] Mygind ND,Nielsen SH,Michelsen MM,et al. Proteoglycan remodeling is accelerated in females with angina pectoris and diffuse myocardial fibrosis:the iPOWER study[J]. Cardiovasc Transl Res,2021,14(5):921-929.
[3] Ulu?/span>ay S,?/span>am FS,Bat?/span>r MB,et al. A novel association between TGFb1 and ADAMTS4 in coronary artery disease:a new potential mechanism in the progression of atherosclerosis and diabetes[J]. Anatol J Cardiol,2015,15(10):823-829.
[4] Chang YT,Chan CK,Eriksson I,et al. Versican accumulates in vascular lesions in pulmonary
arterial hypertension[J]. Pulm Circ,2016,6(3):347-359.
[5] Mutgan AC,Radic N,Valzano F,et al. A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension[J]. Am J Physiol Lung Cell Mol Physiol,2024,327(2):L173-L188.
[6] Hulin A,Deroanne CF,Lambert CA,et al. Metallothionein-dependent up-regulation of TGF-β2 participates in the remodelling of the myxomatous mitral valve[J]. Cardiovasc Res,2012,93(3):480-489.
[7] Islam S,Watanabe H. Versican:a dynamic regulator of the extracellular matrix[J]. Histochem Cytochem,2020,68(11):763-775.
[8] Evanko SP,Angello JC,Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol,1999,19(4):1004-1013.
[9] Wu YJ,La PDP,Wu J. The interaction of versican with its binding partners[J]. Cell Res,2005,15(7):483-494.
[10] MikamiT,KitagawaH.Biosynthesis and func-tion of chondroitin sulfate[J]. Biochim Biophys Acta,2013,1830(10):4719-4733.
[11] 司雨,房俊强,高向东,等. 硫酸软骨素蛋白聚糖的研究进展[J]. 药学进展,2023,472):125-134.
[12] Theocharis AD,Skandalis SS,Gialeli C,et al. Extracellular matrix structure[J]. Adv Drug Deliv Rev,2016,97:4-27.
[13] Barallobre-Barreiro J,Radovits T,Fava M,et al. Extracellular matrix in heart failure:role of ADAMTS5 in proteoglycan remodeling[J]. Circulation,2021,144(25):2021-2034.
[14] Christensen G,Herum KM,Lunde IG.?Sweet,yet underappreciated:proteoglycans and extracellular matrix remodeling in heart disease[J].?Matrix Biol,2019,75(76):286-299.
[15] Zhao RR,Ackers-Johnson M,Stenzig J,et al.Targeting chondroitin sulfate glycosaminoglycans to treat cardiac fibrosis in pathological remodeling[J].?Circulation,2018,137:2497-2513.
[16] Suwan K,Choocheep K,Hatano S,et al. Versican/PG-M assembles hyaluronan into extracellular matrix and inhibits CD44-mediated Signaling toward premature senescence in embryonic fibroblasts[J]. Biol Chem,2009,284:8596-8604.
[17] Wu YJ,La Pierre DP,Wu J,et al.?The interaction of versican with its binding partners[J].?Cell Res,2005,15:483-494.
[18] Mjaatvedt CH,Yamamura H,Capehart AA,?et al. The Cspg2 gene,disrupted in the hdf mutant,is required for right cardiac chamber and endocardial cushion formation[J]. Dev Biol,1998,202(1):56-66.
[19] Yamamura H,Zhang M,Markwald RR,et al.?A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse[J]. Dev. Biol,1997,186(1):58-72.
[20] 盛鑫强.血清骨膜蛋白水平对急性心肌梗死患者PCI术后心室重构的预测价值[D]. 石家庄河北医科大学,2023.
[21] Otsuka F,Kramer MC,Woudstra P,et al. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteriesa pathology study[J]. Atherosclerosis,2015,241(2):772-782.?
[22] Wight TN,Merrilees MJ. Proteoglycans in atherosclerosis and restenosis:key roles for versican[J]. Circ Res,2004,94(9):1158-1167.
[23] Huang R,Merrilees MJ,Braun K,et al.Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury[J]. Circ Res,2006,98(3):370-377.
[24] Theocharis AD,Tsolakis I,Hjerpe A,et al. Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V(0)[J]. Atherosclerosis,2001,154:367-376.
[25] Theocharis AD,Tsolakis I,Hjerpe A,et al. Versican undergoes specific alterations in the fine molecular structure and organization in human aneurysmal abdominal aortas[J]. Biomed Chromatogr,2003,17:411-416.
[26] Didangelos A,Yin X,Mandal K,et al. Extracellular matrix composition and remodeling in human abdominal aortic aneurysms:a proteomics approach[J]. Mol Cell Proteomics,2011,10(8):M111.008128.
[27] Kenagy RD,Plaas AH,Wight TN. Versican degradation and vascular disease[J].Trends Cardiovasc Med,2006,16:209-215.
[28] Lijnen HR. lasmin and matrix metalloproteinases in vascular remodeling[J].Thromb Haemost,2001,86:324-333.
[29] Wang Y,Huang HY,Bian GL,et al. A Functional variant of SMAD4 enhances thoracic aortic aneurysm and dissection risk through promoting smooth muscle cell apoptosis and proteoglycan degradation[J].EBioMedicine,2017,21:197-205.
[30] Azeloglu EU,Albro MB,Thimmappa VA,et al. Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta[J]. Physiol Heart Circ Physiol,2008,294(3):H1197-H1205.
[31] Roccabianca S,Ateshian GA,Humphrey JD. Biomechanical roles of medial pooling of glycosaminoglycans in thoracic aortic dissection[J]. Biomech Model Mechanobiol,2014,13(1):13-25.
[32] Cikach FS,Koch CD,Mead TJ,et al. Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection[J]. JCI Insight,2018,3(5):e97167.
[33] Taniguchi N,Nakamura T,Sawada T,et al.Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction(EPOC-AMI):a pilot,randomized,placebo-contro-lled study[J]. Circ J,2010,74(11):2365-2371.
[34] Tan HT,Lim TK,Richards AM,et al. Unravelling the proteome of degenerative human mitral valves[J].Proteomics,2015,15(17):2934-2944.
[35] Wirrig EE,Snarr BS,Chintalapudi MR,et al.Cartilage link protein 1(Crtl1),an extracellular matrix component playing an important role in heart development[J]. Dev Biol,2007,310(2):291-303.
[36] Hirose J,Kawashima H,Yoshie O,et al. Versican interacts with chemokines and modulates cellular responses[J]. J Biol Chem,2001,276(7):5228-5234.
[37] Kawashima H,Hirose M,Hirose J,et al. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan,versican,to L-selectin,P-selectin,and CD44[J]. J Biol Chem,2000,275(45):35448-35456.
[38] Frangogiannis NG. Transforming growth factor-β in myocardial disease[J]. Nat Rev Cardiol,2022,19(7):435-455.
[39] Hao DJ,Qin Y,Zhou SJ,et al. Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping[J].J Pharm Anal,2024,14(3):335-347.
[40] Feng J,Li Y,Li Y,et al. Versican promotes cardiomyocyte proliferation and cardiac repair[J]. Circulation,2024,149(13):1004-1015.
[41] Vistnes M,Aronsen JM,Lunde IG,et al. Pentosan polysulfate decreases myocardial expression of the extracellular matrix enzyme AD AMTS4 and improves cardiac function in vivo in rats subjected to pressure overload by aortic banding[J].?PLoS One,2014,9(3):e89621.
[42] Sasi A,Romaine A,Erusappan PM,et al. Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development[J]. Matrix Biol Plus,2023,19-20.
[43] Wight TN,Kang I,Evanko SP,et al. Versican—A critical extracellular matrix regulator of immunity and inflammation[J]. Front Immunol,2020,11:512.
[44] Fox KF,Cowie MR,Wood DA,et al. Coronary artery disease as the cause of incident heart failure in the population[J]. Eur Heart,2001,22(3):228-236.
[45] Chabior A,G?secka A,Marchel M,et al. Expression of versican mRNA transcript to
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(6):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(6):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]